Ender holds a PhD in Biomedicine and serves as CEO, leading initiatives in biotech and real estate investment. His research expertise spans genetics and neuroimaging, with specialized knowledge in AI, machine learning, and biomarkers. He combines scientific insight with entrepreneurial leadership in advancing biotechnology and real estate ventures.

‌